-
-
-
-
-
-
-
Genentech launches direct-to-patient program for flu drug Xofluza
-
-
-
-
-
-
-
Roche's (RHHBY) Genentech presents results from Phase 3 study of Lunsumio
-
-
-
-
-
-
-
Rogers (ROG) Misses Q4 EPS by 38c ; Offers Guidance
-
-
-
-
-
-
-
Rogers (ROG) Tops Q2 EPS by 9c, provides guidance
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

